Stocktoria
RetinalGenix Technologies Inc. RTGN
OTC · OOTC · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2022-01-07
RetinalGenix Technologies Inc. financials (annual, from 10-K)
Bars are annual figures from 2020 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| R&D expense | $83,040 | $373,271 | $524,183 | — | $680,293 | $431,557 |
| Interest expense | — | — | $3,840 | $5,140 | $2,619 | — |
| Net income | -$2.4M | -$4.3M | -$2.1M | -$3.9M | -$2.2M | -$2.1M |
| EPS (diluted) | $-0.13 | $-0.24 | $-0.12 | $-0.25 | — | — |
| Operating cash flow | -$558,350 | -$741,936 | -$451,661 | -$199,287 | -$1.2M | -$1.4M |
| Cash & equivalents | — | — | — | $38 | $4,947 | $2,219 |
| Total assets | $21,041 | $14,946 | $156 | $294 | $4,947 | $61,075 |
| Total liabilities | $2.3M | $1.5M | $1.4M | $1.1M | $469,622 | $141,431 |
| Shareholders' equity | -$2.3M | -$1.5M | -$1.4M | -$1.1M | -$464,675 | -$80,356 |
Source: SEC EDGAR filings · CIK 0001836295 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.